Page last updated: 2024-10-22

albuterol and Arrhythmogenic Right Ventricular Dysplasia

albuterol has been researched along with Arrhythmogenic Right Ventricular Dysplasia in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Arrhythmogenic Right Ventricular Dysplasia: A congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the RIGHT VENTRICLE wall and loss of myocardial cells. Primary injuries usually are at the free wall of right ventricular and right atria resulting in ventricular and supraventricular arrhythmias.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boucher, A1
Payen, C1
Garayt, C1
Ibanez, H1
Dieny, A1
Doche, C1
Chuniaud, C1
Descotes, J1

Other Studies

1 other study available for albuterol and Arrhythmogenic Right Ventricular Dysplasia

ArticleYear
Salbutamol misuse or abuse with fatal outcome: a case-report.
    Human & experimental toxicology, 2011, Volume: 30, Issue:11

    Topics: Adrenergic beta-2 Receptor Agonists; Adult; Albuterol; Arrhythmogenic Right Ventricular Dysplasia; A

2011